These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 26318500)

  • 1. Trends in Outcomes of Revascularization for Left Main Coronary Disease or Three-Vessel Disease With the Routine Incorporation of Fractional Flow Reserve in Real Practice.
    Ahn JM; Yoon SH; Roh JH; Lee PH; Chang M; Park HW; Lee JY; Kang SJ; Park DW; Lee SW; Kim YH; Lee CW; Han S; Park SW; Park SJ
    Am J Cardiol; 2015 Oct; 116(8):1163-71. PubMed ID: 26318500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 Trial: a comparison of fractional flow reserve-guided percutaneous coronary intervention and coronary artery bypass graft surgery in patients with multivessel coronary artery disease.
    Zimmermann FM; De Bruyne B; Pijls NH; Desai M; Oldroyd KG; Park SJ; Reardon MJ; Wendler O; Woo J; Yeung AC; Fearon WF
    Am Heart J; 2015 Oct; 170(4):619-626.e2. PubMed ID: 26386784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease: 5-Year Outcomes of the PRECOMBAT Study.
    Ahn JM; Roh JH; Kim YH; Park DW; Yun SC; Lee PH; Chang M; Park HW; Lee SW; Lee CW; Park SW; Choo SJ; Chung C; Lee J; Lim DS; Rha SW; Lee SG; Gwon HC; Kim HS; Chae IH; Jang Y; Jeong MH; Tahk SJ; Seung KB; Park SJ
    J Am Coll Cardiol; 2015 May; 65(20):2198-206. PubMed ID: 25787197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
    Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
    Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of age on fractional flow reserve-guided percutaneous coronary intervention: a FAME (Fractional Flow Reserve versus Angiography for Multivessel Evaluation) trial substudy.
    Lim HS; Tonino PA; De Bruyne B; Yong AS; Lee BK; Pijls NH; Fearon WF
    Int J Cardiol; 2014 Nov; 177(1):66-70. PubMed ID: 25499342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in the outcomes of percutaneous coronary intervention with the routine incorporation of fractional flow reserve in real practice.
    Park SJ; Ahn JM; Park GM; Cho YR; Lee JY; Kim WJ; Han S; Kang SJ; Park DW; Lee SW; Kim YH; Lee CW; Mintz GS; Park SW
    Eur Heart J; 2013 Nov; 34(43):3353-61. PubMed ID: 24092248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term clinical outcome after fractional flow reserve-guided percutaneous coronary revascularization in patients with small-vessel disease.
    Puymirat E; Peace A; Mangiacapra F; Conte M; Ntarladimas Y; Bartunek J; Vanderheyden M; Wijns W; De Bruyne B; Barbato E
    Circ Cardiovasc Interv; 2012 Feb; 5(1):62-8. PubMed ID: 22319067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary Artery Bypass Grafting or Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Diabetic Patients With Multivessel Disease.
    Di Gioia G; Soto Flores N; Franco D; Colaiori I; Sonck J; Gigante C; Kodeboina M; Bartunek J; Vanderheyden M; Van Praet F; Casselman F; Degriek I; Stockman B; Barbato E; Collet C; De Bruyne B
    Circ Cardiovasc Interv; 2020 Oct; 13(10):e009157. PubMed ID: 33040579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six-Year Follow-Up of Fractional Flow Reserve-Guided Versus Angiography-Guided Coronary Artery Bypass Graft Surgery.
    Fournier S; Toth GG; De Bruyne B; Johnson NP; Ciccarelli G; Xaplanteris P; Milkas A; Strisciuglio T; Bartunek J; Vanderheyden M; Wyffels E; Casselman F; Van Praet F; Stockman B; Degrieck I; Barbato E
    Circ Cardiovasc Interv; 2018 Jun; 11(6):e006368. PubMed ID: 29848611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Am J Cardiol; 2014 Aug; 114(4):555-61. PubMed ID: 24996550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study.
    Pijls NH; Fearon WF; Tonino PA; Siebert U; Ikeno F; Bornschein B; van't Veer M; Klauss V; Manoharan G; Engstrøm T; Oldroyd KG; Ver Lee PN; MacCarthy PA; De Bruyne B;
    J Am Coll Cardiol; 2010 Jul; 56(3):177-84. PubMed ID: 20537493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery.
    Fearon WF; Zimmermann FM; De Bruyne B; Piroth Z; van Straten AHM; Szekely L; Davidavičius G; Kalinauskas G; Mansour S; Kharbanda R; Östlund-Papadogeorgos N; Aminian A; Oldroyd KG; Al-Attar N; Jagic N; Dambrink JE; Kala P; Angerås O; MacCarthy P; Wendler O; Casselman F; Witt N; Mavromatis K; Miner SES; Sarma J; Engstrøm T; Christiansen EH; Tonino PAL; Reardon MJ; Lu D; Ding VY; Kobayashi Y; Hlatky MA; Mahaffey KW; Desai M; Woo YJ; Yeung AC; Pijls NHJ;
    N Engl J Med; 2022 Jan; 386(2):128-137. PubMed ID: 34735046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes and comparison after conventional coronary artery bypass grafting for left main disease between patients classified as percutaneous coronary intervention recommendation classes II and III.
    Cho Y; Misumi T; Shimura S; Aki A; Furuya H; Odagiri S; Okada K; Ueda T
    Eur J Cardiothorac Surg; 2014 Mar; 45(3):431-7. PubMed ID: 23979988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fractional flow reserve to guide and to assess coronary artery bypass grafting.
    Pellicano M; De Bruyne B; Toth GG; Casselman F; Wijns W; Barbato E
    Eur Heart J; 2017 Jul; 38(25):1959-1968. PubMed ID: 28025191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of diabetes mellitus on patients with unprotected left main coronary artery lesion disease treated with either percutaneous coronary intervention or coronary-artery bypass grafting.
    Luo Y; Yu X; Chen F; Du X; He J; Gao Y; Zhang X; Zhang Y; Ren X; Lv S; Ma C
    Coron Artery Dis; 2012 Aug; 23(5):322-9. PubMed ID: 22750912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.
    Park DW; Kim YH; Yun SC; Lee JY; Kim WJ; Kang SJ; Lee SW; Lee CW; Kim JJ; Choo SJ; Chung CH; Lee JW; Park SW; Park SJ
    J Am Coll Cardiol; 2010 Oct; 56(17):1366-75. PubMed ID: 20946993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
    Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW;
    Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Five-Year Outcome of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Triple-Vessel Coronary Artery Disease (from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2).
    Shiomi H; Morimoto T; Furukawa Y; Nakagawa Y; Tazaki J; Sakata R; Okabayashi H; Hanyu M; Shimamoto M; Nishiwaki N; Komiya T; Kimura T;
    Am J Cardiol; 2015 Jul; 116(1):59-65. PubMed ID: 25956622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term clinical outcome after fractional flow reserve- versus angio-guided percutaneous coronary intervention in patients with intermediate stenosis of coronary artery bypass grafts.
    Di Serafino L; De Bruyne B; Mangiacapra F; Bartunek J; Agostoni P; Vanderheyden M; Scognamiglio G; Heyndrickx GR; Wijns W; Barbato E
    Am Heart J; 2013 Jul; 166(1):110-8. PubMed ID: 23816029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.